FDA Pulls US Authorization for Eli Lilly ' s COVID Drug Bebtelovimab FDA Pulls US Authorization for Eli Lilly ' s COVID Drug Bebtelovimab
Eli Lilly ' s COVID-19 drug bebtelovimab is not currently authorized for emergency use in the United States, the Food and Drug Administration said, citing it is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
More News: COVID-19 | Emergency Medicine | Food and Drug Administration (FDA) | Infectious Diseases | Intensive Care | USA Health